[{"address1": "11682 El Camino Real", "address2": "Suite 120", "city": "San Diego", "state": "CA", "zip": "92130", "country": "United States", "phone": "858 771 9307", "website": "https://ars-pharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions. The company is involved in the development of neffy, a needle-free and low-dose intranasal epinephrine nasal spray for rescue medication for people with Type I severe allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. The company was founded in 2015 and is headquartered in San Diego, California.", "fullTimeEmployees": 162, "companyOfficers": [{"maxAge": 1, "name": "Mr. Richard E. Lowenthal M.B.A., M.S., MSMSEL", "age": 58, "title": "Co-Founder, President, CEO & Director", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 3332915, "exercisedValue": 0, "unexercisedValue": 3757481}, {"maxAge": 1, "name": "Dr. Sarina  Tanimoto M.B.A., M.D.", "age": 55, "title": "Co-Founder & Chief Medical Officer", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 2936973, "exercisedValue": 0, "unexercisedValue": 520353}, {"maxAge": 1, "name": "Mr. Brian T. Dorsey M.S.", "age": 55, "title": "Chief Operating Officer", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 706970, "exercisedValue": 0, "unexercisedValue": 4750777}, {"maxAge": 1, "name": "Dr. Robert  Bell Ph.D.", "title": "Co-Founder & Chief Science Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kathleen D. Scott CPA", "title": "Chief Financial Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alexander A. Fitzpatrick Esq.", "age": 57, "title": "Chief Legal Officer & Secretary", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 677145, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Relovsky", "title": "Senior Vice President of Marketing", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lynda  Harris", "title": "Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Justin  Chakma", "age": 34, "title": "Chief Business Officer", "yearBorn": 1990, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Harris  Kaplan M.B.A.", "age": 72, "title": "Executive Vice President of Commercial Strategy", "yearBorn": 1952, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 10, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 10, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 6.73, "open": 6.69, "dayLow": 6.66, "dayHigh": 7.695, "regularMarketPreviousClose": 6.73, "regularMarketOpen": 6.69, "regularMarketDayLow": 6.66, "regularMarketDayHigh": 7.695, "payoutRatio": 0.0, "beta": 0.817, "forwardPE": -9.986842, "volume": 3896277, "regularMarketVolume": 3896277, "averageVolume": 2613129, "averageVolume10days": 2762520, "averageDailyVolume10Day": 2762520, "bid": 7.55, "ask": 7.64, "bidSize": 3, "askSize": 2, "marketCap": 750260928, "fiftyTwoWeekLow": 6.66, "fiftyTwoWeekHigh": 18.9, "allTimeHigh": 63.41, "allTimeLow": 2.55, "priceToSalesTrailing12Months": 5.2549586, "fiftyDayAverage": 9.4299, "twoHundredDayAverage": 12.93335, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1382117888, "profitMargins": -0.56061, "floatShares": 105406228, "sharesOutstanding": 98848611, "sharesShort": 19756847, "sharesShortPriorMonth": 21690186, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.1999, "heldPercentInsiders": 0.16826001, "heldPercentInstitutions": 0.87571, "shortRatio": 8.97, "shortPercentOfFloat": 0.32560003, "impliedSharesOutstanding": 98848611, "bookValue": 1.494, "priceToBook": 5.0803213, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -80040000, "trailingEps": -0.81, "forwardEps": -0.76, "enterpriseToRevenue": 9.681, "enterpriseToEbitda": -15.39, "52WeekChange": -0.4463895, "SandP52WeekChange": 0.1028198, "quoteType": "EQUITY", "currentPrice": 7.59, "targetHighPrice": 38.0, "targetLowPrice": 12.0, "targetMeanPrice": 28.66667, "targetMedianPrice": 31.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 288208992, "totalCashPerShare": 1.458, "ebitda": -89807000, "totalDebt": 169804992, "quickRatio": 6.406, "currentRatio": 6.66, "totalRevenue": 142772000, "debtToEquity": 115.001, "revenuePerShare": 1.454, "returnOnAssets": -0.19221, "returnOnEquity": -0.45916, "grossProfits": 114873000, "freeCashflow": -56190248, "operatingCashflow": -85377000, "revenueGrowth": 14.716, "grossMargins": 0.80459, "ebitdaMargins": -0.62902, "operatingMargins": -1.6366299, "financialCurrency": "USD", "symbol": "SPRY", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "fiftyDayAverageChange": -1.8399, "fiftyDayAverageChangePercent": -0.19511342, "twoHundredDayAverageChange": -5.3433495, "twoHundredDayAverageChangePercent": -0.41314507, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Silverback Therapeutics, Inc.", "nameChangeDate": "2025-11-21", "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1607092200000, "postMarketChangePercent": 0.0, "postMarketPrice": 7.59, "postMarketChange": 0.0, "regularMarketChange": 0.86, "regularMarketDayRange": "6.66 - 7.695", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 2613129, "corporateActions": [], "postMarketTime": 1763773150, "regularMarketTime": 1763758801, "exchange": "NGM", "messageBoardId": "finmb_585213447", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 12.7786, "regularMarketPrice": 7.59, "shortName": "ARS Pharmaceuticals, Inc.", "longName": "ARS Pharmaceuticals, Inc.", "marketState": "CLOSED", "fiftyTwoWeekLowChange": 0.9300003, "fiftyTwoWeekLowChangePercent": 0.13963969, "fiftyTwoWeekRange": "6.66 - 18.9", "fiftyTwoWeekHighChange": -11.309999, "fiftyTwoWeekHighChangePercent": -0.5984127, "fiftyTwoWeekChangePercent": -44.63895, "earningsTimestamp": 1762781400, "earningsTimestampStart": 1762781400, "earningsTimestampEnd": 1762781400, "earningsCallTimestampStart": 1762781400, "earningsCallTimestampEnd": 1762781400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.81, "epsForward": -0.76, "epsCurrentYear": -1.795, "priceEpsCurrentYear": -4.2284126, "displayName": "ARS Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-11-22"}]